RobertCavaliereMD

Neurology • Jacksonville, FL

Neurooncology

Director, Neuro-oncology

Join to view full profile

Dr. Cavaliere is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cavaliere's full profile

Already have an account?

Office
1301 Palm Ave
Jacksonville, FL 32207
Phone+1 904-202-7300

Fax+1 904-202-2754

Education & Training

University of Virginia Medical CenterFellowship, Neuro-Oncology, 2003 - 2005
University of Virginia Medical CenterResidency, Neurology, 2000 - 2003
Westchester Medical CenterInternship, Internal Medicine, 1999 - 2000
New York Medical CollegeClass of 1999

Certifications & Licensure

FL State Medical License 2015 - 2026
OH State Medical License 2005 - 2017
VA State Medical License 2000 - 2006
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Sunitinib in Treating Patients With Recurrent Malignant Gliomas Start of enrollment: 2007 Jun 01
Completed
Phase 2
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
Completed
Phase 1
LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma Start of enrollment: 2020 Oct 21
Active, not recruiting
Phase 2
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Active, not recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

55 citations
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: An NRG oncology RTOG group study
H. Ian Robins, Peixin Zhang, Mark R. Gilbert, Arnab Chakravarti, John de Groot
Journal of Neuro-Oncology. 2016-01-01
123 citations
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.
Lee A. Wheeler, Andrea G. Manzanera, Susan Bell, Robert Cavaliere, John M. McGregor
Neuro-Oncology. 2015-11-01
102 citations
Low-grade gliomas: an update on pathology and therapy
Robert Cavaliere, Maria Beatriz Lopes, David Schiff
The Lancet. Neurology. 2005-11-01

Press Mentions

Mason Health Welcomes New Specialty Providers: Danielle Blood, MD, Robert Cavaliere, DPM, and Ross Vogelgesang, MDOctober 5th, 2021
The Players Tees up Big Surprise for Young Cancer PatientsMarch 10th, 2021